DS-KCF: a real-time tracker for RGB-D data

© 2016 The Author(s) We propose an RGB-D single-object tracker, built upon the extremely fast RGB-only KCF tracker that is able to exploit depth information to handle scale changes, occlusions, and shape changes. Despite the computational demands of the extra functionalities, we still achieve real-time performance rates of 35–43 fps in MATLAB and 187 fps in our C++ implementation. Our proposed method includes fast depth-based target object segmentation that enables, (1) efficient scale change handling within the KCF core functionality in the Fourier domain, (2) the detection of occlusions by temporal analysis of the target’s depth distribution, and (3) the estimation of a target’s change of shape through the temporal evolution of its segmented silhouette allows. Finally, we provide an in-depth analysis of the factors affecting the throughput and precision of our proposed tracker and perform extensive comparative analysis. Both the MATLAB and C++ versions of our software are available in the public domain

Antiestrogenic therapy in breast cancer and endometrial modifications

The aim of this retrospective study was to detect endometrial lesions in tamoxifen breast cancer users (menopausal state related). The meaning of genital bleeding during the treatment and the actual incidence of benign and malignant pathology of the endometrium related to length of treatment was also evaluated. Tamoxifen (TMX) is a nonsteroidal triphenylene derivate with clear antiestrogenic properties on the breast which is used as adjuvant treatment for breast cancer; potential adverse effects include endometrial lesions. Three hundred and sixty-six breast cancer patients were enrolled in this study; 292 patients were treated with 20 mg/daily of TMX as adjuvant therapy and the remaining 74 did not receive therapy. All patients were subdivided in premenopausal and postmenopausal, asymptomatic and symptomatic groups. All patients underwent ultrasound scans (to examine endometrial thickness) and hysteroscopic examinations before treatment and after one, three and five years. Endometrial biopsy under direct hysteroscopic vision was systematically performed. The pathological histology reports were classified under polyps, simple hyperplasia, complex hyperplasia, atypical hyperplasia, and carcinoma. A higher incidence of endometrial pathology was found only in symptomatic postmenopausal TMX treated patients (27.2% vs 19.5%) between the third and fifth year of treatment